Enzolytics Inc.

OTC:ENZC

0.02176 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q32021 Q22021 Q12020 Q42011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q32008 Q22008 Q12007 Q42007 Q3
Revenue 0000.0850.040000000.2000.0150.0060.0120.0130.0080.004-0.0010.0060.0080.0010.0030.0010000
Cost of Revenue 0.0060.0060.0060.0110.0060.0060.01700.0030.0020.00900.0040.0040000000000000000
Gross Profit -0.006-0.006-0.0060.0740.034-0.006-0.0170-0.003-0.002-0.0090.2-0.004-0.0040.0150.0060.0120.0130.0080.004-0.0010.0060.0080.0010.0030.0010000
Gross Profit Ratio 0000.870.8610000001001111111111110000
Reseach & Development Expenses 0000.3060.2890.00100.1240.4110.55600.027000000000000000000
General & Administrative Expenses 000000000000000.22600.8030.63000000000000
Selling & Marketing Expenses 000000000000000000000000000000
SG&A 0.017-0.0220.1672.020.9930.4120.9210.2390.3590.270.370.3670.560.9150.2260.2510.8030.630.3220.5150.6060.1950.0850.0510.1180.160.0180.01800.002
Other Expenses 0000000000000000000000000000-0.0260
Operating Expenses 0.017-0.0220.1672.3261.2820.4130.9210.3630.770.8260.370.3940.560.9150.2290.2540.8070.6330.3250.5180.6090.1980.0890.0540.120.1630.0180.018-0.0260.002
Operating Income -0.0220.017-0.173-2.252-1.248-0.418-0.938-0.363-0.773-0.828-0.379-0.208-0.564-0.919-0.214-0.248-0.795-0.62-0.946-0.514-0.61-0.191-0.081-0.053-0.117-0.162-0.018-0.018-0.026-0.002
Operating Income Ratio 000-26.507-31.516000000-1.04200-13.943-39.813-68.62-47.967-116.508-118.496513.688-29.644-9.78-45.908-34.874-120.2840000
Total Other Income Expenses Net -0.009-0.018-0-0.0180.03-0.009-0.571-0.0170.549-0.017-0.009-0.0090.769-10.224-0.0070-4.613-0.011-0.008-0.006-0.018-0.006-0.003-0.008000.018000
Income Before Tax -0.031-0.002-0.173-2.27-1.218-0.428-1.509-0.38-0.224-0.845-0.389-0.2180.205-11.143-0.2210-5.408-0.631-1.576-0.52-0.628-0.197-0.0840000-0.0180-0.002
Income Before Tax Ratio 000-26.724-30.762000000-1.08800-14.4130-466.85-48.835-194.004-119.931528.439-30.559-10.1180000000
Income Tax Expense 0-0-0-0-0-00-0.027-0-00-00000.007-3.29200.63700000.0080.0030.0070.01800.0260
Net Income -0.031-0.002-0.173-2.27-1.218-0.428-1.509-0.38-0.224-0.845-0.389-0.2180.205-11.143-0.221-0.255-5.408-0.631-0.954-0.52-0.628-0.197-0.084-0.061-0.12-0.169-0.018-0.018-0.026-0.002
Net Income Ratio 000-26.724-30.762000000-1.08800-14.413-41.017-466.85-48.835-117.484-119.931528.439-30.559-10.118-52.989-35.763-125.620000
EPS 00-0-0.001-0-0-0.001-0-0-0-0-00-0.004-5.74-4.860-52.82-137.59-106.380-52.99-23.21-16.920-471.250-6.48-9.61-0.57
EPS Diluted 00-0-0.001-0-0-0.001-0-0-0-0-00-0.004-5.74-4.860-52.82-137.59-106.380-52.99-23.21-16.920-471.250-6.48-9.61-0.57
EBITDA -0.0170.022-0.167-2.241-1.187-0.413-0.921-0.363-0.77-0.826-0.37-0.1940.219-0.915-0.211-0.244-5.362-0.617-0.943-0.511-0.607-0.188-0.076-0.05-0.114-0.159-0.018-0.018-0.026-0.002
EBITDA Ratio 000-26.377-29.978000000-0.96900-13.742-39.316-462.82-47.728-116.127-117.782511.088-29.167-9.219-43.747-34.238-118.0780000